GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $294,000 | +34.9% | 5,500 | +7.8% | 0.10% | +31.9% |
| Q4 2014 | $218,000 | -6.8% | 5,100 | 0.0% | 0.07% | -6.5% |
| Q3 2014 | $234,000 | -20.4% | 5,100 | -7.3% | 0.08% | -18.9% |
| Q2 2014 | $294,000 | -3.6% | 5,500 | -3.5% | 0.10% | -10.4% |
| Q1 2014 | $305,000 | -2.9% | 5,700 | -3.0% | 0.11% | -4.5% |
| Q4 2013 | $314,000 | +5.0% | 5,875 | -1.4% | 0.11% | -0.9% |
| Q3 2013 | $299,000 | +0.3% | 5,960 | 0.0% | 0.11% | -5.9% |
| Q2 2013 | $298,000 | – | 5,960 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |